For investors seeking momentum, Vanguard MidCap ETF (VO - Free Report) is probably on radar. The fund just hit a 52-week high and is up 42.3% from its 52-week low price of $168.17 per share.
But are more gains in store for this ETF? Let’s take a quick look at the fund and the near-term outlook on it to get a better idea on where it might be headed:
VO in Focus
This fund offers exposure to U.S. mid-cap stocks with key holdings in technology, consumer discretionary, industrials, healthcare and financials. The fund charges 4 basis points in annual fees (see: all the Mid Cap Blend ETFs here).
Why the Move?
The mid-cap space of the broad U.S. stock market has been an area to watch lately given the soaring stock market. While rounds of upbeat corporate earnings and Q2 optimism are driving investors’ sentiment, the rising cases of the Delta variant of COVID-19 are weighing on stocks. In this scenario, mid-cap funds offer the best of both worlds — growth and stability — when compared to the small-cap and large-cap counterparts.
More Gains Ahead?
Currently, VO has a Zacks ETF Rank #2 (Buy) with a Medium risk outlook, suggesting continued outperformance in the months ahead. Further, many of the segments that make up this ETF have a strong Zacks Industry Rank. So, there is definitely some promise for those who want to ride this surging ETF a little further.
Want key ETF info delivered straight to your inbox?
Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week. Get it free >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
For investors seeking momentum, Vanguard MidCap ETF (VO - Free Report) is probably on radar. The fund just hit a 52-week high and is up 42.3% from its 52-week low price of $168.17 per share.
But are more gains in store for this ETF? Let’s take a quick look at the fund and the near-term outlook on it to get a better idea on where it might be headed:
VO in Focus
This fund offers exposure to U.S. mid-cap stocks with key holdings in technology, consumer discretionary, industrials, healthcare and financials. The fund charges 4 basis points in annual fees (see: all the Mid Cap Blend ETFs here).
Why the Move?
The mid-cap space of the broad U.S. stock market has been an area to watch lately given the soaring stock market. While rounds of upbeat corporate earnings and Q2 optimism are driving investors’ sentiment, the rising cases of the Delta variant of COVID-19 are weighing on stocks. In this scenario, mid-cap funds offer the best of both worlds — growth and stability — when compared to the small-cap and large-cap counterparts.
More Gains Ahead?
Currently, VO has a Zacks ETF Rank #2 (Buy) with a Medium risk outlook, suggesting continued outperformance in the months ahead. Further, many of the segments that make up this ETF have a strong Zacks Industry Rank. So, there is definitely some promise for those who want to ride this surging ETF a little further.
Want key ETF info delivered straight to your inbox?
Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week. Get it free >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on VO - FREE